The Way Food Is Processed Changes What Happens Deep in Your Small Intestine

Most gut microbiome research focuses on the colon, where microbial populations are dense and relatively easy to sample. But a new preprint from G Frost, N Fernandes, M Cai, F Warren, A Duncan, and colleagues suggests the small intestine deserves far more attention: the structural form of the food you eat, not just its nutritional content, appears to drive rapid and distinct changes in metabolites, microbial communities, and gut hormone release all the way from the duodenum to the ileum.

Chickpea structure controls nutrient delivery along the gut

The study enrolled ten healthy adults in a randomized, double-blinded, crossover trial. Each participant swallowed a naso-enteral tube that allowed researchers to collect samples from four sites: the oral cavity, stomach, duodenum, and ileum. The three test meals were all chickpea-based but differed sharply in cellular integrity: broken cell (BC) meals were fully disrupted, single cell (SC) meals were intact individual cells, and clustered cell (CC) meals were intact cell aggregates.

The differences in what arrived where, and when, were striking. BC meals generated an early spike of maltose in the duodenum, reflecting rapid starch release from disrupted cells. Intact structures, SC and CC, held their carbohydrates back: beta-glucose and beta-maltose concentrations were markedly higher in the ileum for those meals at 120 minutes, signalling that starch digestion was still unfolding far downstream. Amino acid concentrations followed a similar pattern, with SC and CC meals showing higher ileal levels than BC at the 120-minute mark.

Bile acids were also shaped by food structure. Taurocholic acid and glycocholic acid were higher in the duodenum for SC meals than BC, and total bile acid concentrations climbed from duodenum to ileum, peaking between 300 and 360 minutes. Short-chain fatty acids (SCFAs) were more abundant in the duodenum than in the stomach across all meals, with butyrate differing between food structures.

Gut hormones GIP, GLP-1, and PYY respond to nutrient timing

The metabolic consequences extended to hormone release. Gastric inhibitory peptide (GIP), which signals glucose absorption, correlated with proximal maltose presence and was higher with BC meals, consistent with the earlier and more concentrated carbohydrate arrival in the upper gut. GLP-1 and PYY, both satiety-linked hormones, showed a second rise later in the study period that corresponded to diverse nutrient arrival in the ileum during what the authors call the late maintenance phase. Bile acids were more closely tied to GLP-1 responses, while fasting SCFAs in the ileum were positively associated with early PYY secretion.

These findings matter because GLP-1 and PYY are the same hormonal targets now attracting enormous pharmaceutical interest for appetite regulation and metabolic disease. The idea that food physical structure, independent of macronutrient composition, could tune how vigorously those signals fire adds a dimension to how gut microbiota and metabolites shape metabolic health that diet-disease research has largely overlooked.

Oral bacteria colonise the ileum after meals

Perhaps the most unexpected finding involves microbial geography. The fasted ileal microbiome was dominated by Haemophilus and Streptococcus, with some colonic strict anaerobes present. When food arrived, microbial numbers dropped but diversity increased, particularly with BC and CC meals. More strikingly, oral species including Rothia aeria and Rothia denticariosa appeared in the ileum postprandially, while strict anaerobes retreated.

Strain-resolved metagenomics identified 106 strains shared between oral and ileal samples across five participants. The proportion of oral-origin strains in the ileal microbiome climbed to as high as 50% after meals, with peaks at 120 minutes and again between 420 and 480 minutes. This two-wave pattern suggests food transit physically carries oral bacteria into the small intestine, and that a second wave may reflect altered mucosal conditions later in digestion.

Researchers also built co-occurrence networks linking microbial species to metabolites. At baseline, those networks were sparse. After meals, integration grew substantially, with strong microbe-metabolite associations appearing at 60 to 120 minutes and again at 360 to 480 minutes. Early associations involved non-adherent shared strains likely metabolising free substrates; late-phase associations featured oral-origin strains such as Eggerthia sulci and Mogibacterium diversum. One oral microbe, Streptococcus parasanguinis, was consistently associated with formate production and PYY signaling across all three meal types. The small intestinal microbiota's emerging regulatory roles in immunity and endocrine function make this oral-ileal bacterial traffic a potentially significant finding.

Limits: ten participants, ileum-only metagenomics

The study is candid about its constraints. Only ten participants completed the trial, and the authors acknowledge that no sample size calculation was feasible given the novelty of the approach. Generalising from ten people, even with a sophisticated crossover design, requires caution. Metagenomic sequencing was restricted to ileal samples because gastric acidity and low microbial abundance made duodenal sequencing impractical. Oral samples were excluded from primary metabolite imputation due to data sparsity. Metabolite identification relied on statistical spectroscopic methods rather than compound spiking, so some assignments carry uncertainty.

Earlier work in animal models has shown that dietary changes can induce early alterations in the small intestine's microbiota and metabolome ahead of systemic metabolic shifts, and research in obese rodents has linked a distinct small intestinal metabolome to obesity that prebiotics may partially reverse. The current human data sit in that broader context but push the resolution considerably further, capturing hour-by-hour changes at multiple gut sites in living people.

What comes next for food structure and small intestine research

The authors frame naso-enteral intubation as a platform for future work, not just a one-off tool. Questions left open include whether the oral-to-ileal bacterial transfer observed here has functional consequences for host immunity or metabolism over longer timescales, whether similar structural effects appear with other plant foods, and whether the hormone response differences between BC and intact cell meals translate into meaningful differences in satiety or glycaemic control in clinical populations.

If intact food structures consistently delay carbohydrate and amino acid delivery to the ileum, and that delay amplifies satiety hormone signals, the implication for dietary guidelines around food processing deserves serious scrutiny. The findings are preliminary, but they point toward a future in which food structure is treated as a biological variable on par with fibre content or glycaemic index, one worth measuring, studying, and potentially designing around.

Evidence rating

EMERGING — 78/100

Caveats:

• This is a preprint and has not yet completed peer review; findings may change.
• Only 10 participants — too small to draw firm population-level conclusions.
• Randomized crossover design is methodologically strong, but metagenomic sequencing was limited to ileal samples; microbial dynamics in the stomach and duodenum remain unmeasured.
• Several metabolite identifications were not confirmed by chemical spiking, which is standard validation practice.
• Associations between oral bacterial strains and hormone signaling are correlational — direct causal mechanisms have not been established.

Randomized, double-blinded, crossover trial in 10 healthy adults using naso-enteral intubation to collect spatiotemporally resolved samples across four GI regions. The small sample limits generalizability, and associations between ileal microbial strains and hormone release are correlational rather than causal. This is a preprint with methodologically novel design, but independent replication in larger cohorts is needed.

References

1. Nadia Fernandes, Mingzhu Cai, Frederick J Warren, et al. (2025). Dietary Modulation of The Human Small Intestine Metabolome and Microbiome. https://doi.org/10.1101/2025.11.25.25340785
2. Sabitha Sasidharan Pillai, Charles A Gagnon, Christy Foster, Ambika P Ashraf (2024). Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae499
3. Renate A. A. A. Ruigrok, Rinse K. Weersma, Arnau Vich Vila (2023). The emerging role of the small intestinal microbiota in human health and disease. Gut Microbes. https://doi.org/10.1080/19490976.2023.2201155
4. Axel Ranson, Marta Vazquez Gomez, Rohia Alili, et al. (2025). Moderate increase in dietary fat induces alterations of microbiota and metabolome along the digestive tract prior to systemic metabolic changes: insights from a pig model. Gut Microbes. https://doi.org/10.1080/19490976.2025.2587964
5. Rachel K. Meyer, Megan A. Bime, Frank A. Duca (2022). Small intestinal metabolomics analysis reveals differentially regulated metabolite profiles in obese rats and with prebiotic supplementation. Metabolomics. https://doi.org/10.1007/s11306-022-01920-9